Scalable AAV production in single use bioreactors
Sponsor
Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
Production of high titer AAV at clinical scales remains a challenge for the gene therapy industry. Developers need to understand how to optimize, scale, and qualify their manufacturing process for AAV production under the tightest of time lines.
Due to high demand in the gene therapy space, effective solutions to address these challenges must be developed and implemented.
This month, Jon Zmuda (Director, Cell Biology, Thermo Fisher Scientific) will discuss how to meet the needs of this fast-moving industry. He will conduct a special Q&A to answer any questions on the demand webinars below and any other AAV production, purification, and process-related questions.
As a webinar attendee, you will learn about:
- Enabling scalable, high-titer AAV production in single use bioreactors
- How to optimize recovery and purity in downstream processing
- Robust and efficient AAV production workflows
Watch: Complete system for AAV production for clinical production: Part 1 - Upstream
Watch: Optimizing vector production and purification to enhance scalable AAV manufacturing
SPEAKERS